Protective effects of a novel glycogen phosphorylase inhibitor against cerebral ischemia-reperfusion injury in mice

Future Med Chem. 2023 Apr;15(7):587-597. doi: 10.4155/fmc-2023-0038. Epub 2023 Apr 25.

Abstract

Aim: To evaluate the effects of a novel glycogen phosphorylase inhibitor (NGPI) on cerebral ischemia-reperfusion injury (CIRI). Methods: Cerebral ischemia was induced in mice using a modified bilateral common carotid artery ligation model. To assess the effects of NGPI against CIRI, mice which had been administered with different doses of NGPI (1.25, 2.5, 5 mg/kg/day) for 7 days before the injury were evaluated for infarct volume, the apoptosis level of brain tissue, integrity of brain tissue and oxidative stress level. Results: NGPI effectively improved the infarct area, apoptosis of neurons, integrity of brain tissue and oxidative stress level of mice with CIRI. Conclusion: NGPI could effectively improve CIRI and deserves further study.

Keywords: cerebral infarction; cerebral ischemia–reperfusion injury; glycogen phosphorylase inhibitor; neuroprotective; oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Brain
  • Brain Ischemia* / drug therapy
  • Infarction
  • Mice
  • Neuroprotective Agents* / pharmacology
  • Neuroprotective Agents* / therapeutic use
  • Oxidative Stress
  • Reperfusion Injury* / drug therapy

Substances

  • Neuroprotective Agents